Seres Therapeutics (1S90.F) Q4 2025 Earnings

Nov 5Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-3.62
-1.31
1
3.32

Details

Expected EPS
0.39724548996
Actual EPS
0.8176872
Surprise EPS
0.42
Surprise Percent
+105.84%

Description

⁨Seres Therapeutics⁩ (⁦1S90.F⁩) has reported earnings of ⁦0.8176872⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts